Send Inquiry

Request To Call Back

Cdoxin 50 mg Injection

Name: Cdoxin 50 mg Injection
Brand: SIDMEX INOVIA PRIVATE LIMITED
Price: 954.0 INR
Availability: InStock

Price 954.0 INR/ Piece

Get a Price/Quote

MOQ : 210 Pieces

Cdoxin 50 mg Injection Specification

Brand Name
Cdoxin 50 mg Injection

Packaging Type
Glass vial

Dosage Form
Injection

Indication
Treatment of various cancers including breast, ovarian, bladder, and lymphomas

Pacakaging (Quantity Per Box)
1 vial per box

Life Span
24 months from manufacturing date

Origin of Medicine
INDIA

Salt Composition
Doxorubicin Hydrochloride

Drug Type
Prescription only, Cytotoxic/Antineoplastic

Ingredients
Doxorubicin Hydrochloride 50 mg

Physical Form
Liquid

Function
Anticancer/Antineoplastic agent

Recommended For
DOCTOR

Dosage
As prescribed by a healthcare professional

Dosage Guidelines
Administered intravenously as per doctors recommendation

Suitable For
Suitable for cancer patients under physician supervision

Quantity
210 Pieces

Storage Instructions
Store below 25C, protect from light

Precautions
Monitor cardiac function, use appropriate precautions with handling and administration (cytotoxic)

Color
Red-orange solution

Strength
50 mg per vial

Adverse Effects
Nausea, vomiting, hair loss, myelosuppression, cardiotoxicity

Route of Administration
Intravenous (IV) use only

Generic Name
Doxorubicin

Prescription Status
Rx - Prescription required

Contraindications
Patients with hypersensitivity to doxorubicin, severe hepatic impairment, recent myocardial infarction

Therapeutic Category
Oncology

Cdoxin 50 mg Injection Trade Information

Minimum Order Quantity
210 Pieces

Supply Ability
5000 Pieces Per Month

Delivery Time
1 Week

About Cdoxin 50 mg Injection

Cdoxin 50 mg Injection is an effective chemotherapy agent used in conjunction with other medications to combat various malignancies, including bladder, breast, lung, stomach, and ovarian cancers. This potent injection is also indicated for the treatment of both Hodgkin's and non-Hodgkin's lymphomas, as well as specific types of leukemia such as acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML). In addition to these, Cdoxin is utilized for managing certain thyroid cancers and soft tissue or bone sarcomas, which are cancers that develop in the bodys muscles and bones. Pediatric patients benefit from Cdoxin as it also targets neuroblastoma, a cancer that originates in nerve cells, and Wilms tumor, a common kidney cancer in children. Its crucial to follow your healthcare providers guidance while using this medication, as Cdoxin may cause side effects, including potential impacts on blood counts and organ function. Regular monitoring and prompt reporting of any adverse reactions are essential for safe treatment. With its broad-spectrum efficacy, Cdoxin 50 mg Injection plays a vital role in the fight against various challenging cancers, contributing significantly to improved patient outcomes.

Potent Oncology Support

Cdoxin 50 mg Injection is a reliable chemotherapeutic solution that targets various malignancies, including breast, ovarian, bladder, and lymphatic cancers. Its efficacy stems from the active ingredient, Doxorubicin Hydrochloride, which is delivered intravenously for rapid and controlled action in clinical settings.

Professional Handling & Administration

Designed exclusively for use by healthcare providers, Cdoxin 50 mg Injection must be handled with appropriate cytotoxic precautions. Only qualified medical professionals should administer this injection to ensure patient safety and proper monitoring throughout the treatment cycle.

Quality and Safety Certifications

Manufactured and distributed in India, Cdoxin 50 mg Injection complies with high standards of pharmaceutical safety. Each glass vial is clearly labeled, with packaging designed to preserve the integrity of this sensitive oncology medication.

FAQ's of Cdoxin 50 mg Injection:

Q: How is Cdoxin 50 mg Injection administered to patients?

A: Cdoxin 50 mg Injection is administered intravenously (IV) by a healthcare professional in a clinical setting, following the exact dosage prescribed by the treating oncologist. Self-administration is not recommended.

Q: What types of cancers can Cdoxin 50 mg Injection treat?

A: Cdoxin 50 mg Injection is indicated for a range of cancers, including breast cancer, ovarian cancer, bladder cancer, and various lymphomas, as determined by a qualified physician.

Q: When should Cdoxin 50 mg Injection not be used?

A: This injection should not be used in patients with known hypersensitivity to doxorubicin, severe hepatic impairment, recent myocardial infarction, or other significant contraindications listed by a medical professional.

Q: Where should Cdoxin 50 mg Injection be stored before use?

A: Store Cdoxin 50 mg Injection below 25C and protect it from light to maintain its stability and effectiveness. It should remain in its original glass vial packaging until use.

Q: What precautions should be taken during the use of Cdoxin 50 mg Injection?

A: Cardiac function should be closely monitored due to the risk of cardiotoxicity. Healthcare professionals must use cytotoxic precautions during handling and administration to protect both the patient and staff.

Q: What are the common adverse effects of Cdoxin 50 mg Injection?

A: Patients may experience side effects such as nausea, vomiting, hair loss, myelosuppression, and potential cardiotoxicity. Any adverse reaction should be promptly reported to the prescribing doctor.

Q: What are the benefits of using Cdoxin 50 mg Injection for cancer patients?

A: Cdoxin 50 mg Injection provides an effective antineoplastic action, helping to manage and treat various cancers under medical supervision, thereby potentially improving patient outcomes in cancer therapy.

Tell us about your requirement